Senior Integration Analyst at Tempus

Chicago, Illinois, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

HealthcareIndustries

Requirements

5+ years of experience in healthcare integration, with at least 3 years working with Epic interfaces
Direct experience with Epic Aura deployments and workflows
Strong understanding of HL7, FHIR, and Epic interoperability tools
Proven track record of supporting clinical or lab ordering and results interfaces
Excellent troubleshooting, problem-solving, and communication skills
Ability to manage multiple projects in a fast-paced environment with competing priorities

Responsibilities

Lead technical design, build, and deployment of Epic integrations, particularly through Aura, supporting ordering, results delivery, and data sharing workflows
Collaborate with hospital IT teams, Epic representatives, and internal stakeholders to define requirements and deliver integration solutions
Configure and validate HL7, FHIR, and API-based interfaces, ensuring compliance with industry standards and partner requirements
Conduct end-to-end testing, troubleshooting, and validation of interfaces and data flows
Act as a subject matter expert (SME) for Epic Aura connectivity and provide guidance to project managers, analysts, and engineers
Support go-live events, monitor integration performance, and resolve production issues in partnership with internal support teams
Document workflows, specifications, and best practices for repeatable deployments

Skills

Epic

Aura

HL7

FHIR

APIs

Interface Configuration

Integration Testing

Troubleshooting

Workflow Design

Healthcare Data

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free